MRCM
TMO icon

M&R Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

M&R Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.42K Hold
12
– – ﹤0.01% 420
2024
Q2 		$6.64K Hold
12
– – ﹤0.01% 418
2024
Q1 		$6.97K Hold
12
– – ﹤0.01% 404
2023
Q4 		$6.37K Buy
+12
New +$5.81K ﹤0.01% 459

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

M&R Capital Management's TMO Position: Q3 2024 in Review

M&R Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2024 at 12 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

M&R Capital Management first reported a position in TMO in Q4 2023 and has held it in 4 quarters since. 2,572 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • M&R Capital Management held 12 shares of Thermo Fisher Scientific worth $7.42K as of Q3 2024.
  • M&R Capital Management left its Thermo Fisher Scientific share count unchanged in Q3 2024.
  • Thermo Fisher Scientific made up ﹤0.01% of M&R Capital Management's portfolio in Q3 2024, its #420 holding.
  • M&R Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 4 quarters since.
  • 2,572 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.